These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1088219)

  • 21. [Levamisole, a chemically defined substance with immunostimulating potential--a review].
    Staber GF
    Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hypothesis. The mechanism of action of levamisole: immune restoration through enhanced cell maturation.
    Amery WK
    J Reticuloendothel Soc; 1978 Aug; 24(2):187-93. PubMed ID: 309007
    [No Abstract]   [Full Text] [Related]  

  • 23. [Targets and mechanisms of levamisole-induced immunostimulation (author's transl)].
    Renoux G; Renoux M
    Nouv Presse Med; 1978 Jan; 7(3):197-201. PubMed ID: 307228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levamisole in rheumatoid arthritis.
    Med J Aust; 1976 Sep; 2(11):400. PubMed ID: 994913
    [No Abstract]   [Full Text] [Related]  

  • 25. [Levamisol in the treatment of recurrent urinary tract infections].
    Lubetkin AM; Remedi RF; Granero M; Brarda O
    Bol Med Hosp Infant Mex; 1979; 36(6):1109-12. PubMed ID: 385017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell responses in microbial infection.
    Modlin RL; Brenner MB
    Curr Opin Immunol; 2009 Aug; 21(4):365-6. PubMed ID: 19643590
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlations of clinical and laboratory effects of treatment with levamisole in autoimmune disease.
    Levy J
    Cancer Treat Rep; 1978 Nov; 62(11):1715-9. PubMed ID: 365326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of delayed hypersensitivity.
    McCluskey RT; Cohen S
    Pathobiol Annu; 1972; 2():111-28. PubMed ID: 4589745
    [No Abstract]   [Full Text] [Related]  

  • 29. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI; Lukach EV; Krivokhatskaia LD
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How do immune cells react to pathogen invasion?].
    Krankenpfl J; 2001; 39(10-12):335. PubMed ID: 11858147
    [No Abstract]   [Full Text] [Related]  

  • 33. Levamisole.
    Beatty DW
    S Afr Med J; 1978 Jan; 53(3):73-4. PubMed ID: 306687
    [No Abstract]   [Full Text] [Related]  

  • 34. [Individual reactivity to Imuran, antithymocytic globulin and levamisol].
    Korcáková L; Rovenský J; Pekárek J; Holub M; Kocandrle V
    Cas Lek Cesk; 1982 Sep; 121(38-39):1180-3. PubMed ID: 6982754
    [No Abstract]   [Full Text] [Related]  

  • 35. [Letter: action of levamisole on the restoration of cellular immunity in man].
    Pasquier P; Vidal M; Couture J; Niel G; Floc'h F; Werner GH
    Nouv Presse Med; 1975 Nov; 4(38):2736. PubMed ID: 1105423
    [No Abstract]   [Full Text] [Related]  

  • 36. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neopterin, a new biochemical marker for the detection of activated T lymphocytes].
    Niederwieser D; Huber C; Wachter H
    Wien Klin Wochenschr; 1983 Mar; 95(5):161-4. PubMed ID: 6602425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-immunologic evaluation of the effect of decaris (levamisole) in chronic lymphoid leukemia].
    Streneva TN; Shalaev VA; Krylova IV
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):20-3. PubMed ID: 6983689
    [No Abstract]   [Full Text] [Related]  

  • 39. Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease.
    Amery WK; Gough DA
    Oncology; 1981; 38(3):168-81. PubMed ID: 7010258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic background of chronic rheumatoid arthritis--its past, present and future].
    Kyogoku K
    Ryumachi; 1974 Jul; 14(2):155-60. PubMed ID: 4616375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.